Clinical and Applied Thrombosis/Hemostasis, 1938-2723

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. 2018
  3. 2017
  4. Safety and Efficacy of Bridging with Low-Molecular-Weight Heparin during Temporary Interruptions of Warfarin: A Register-Based Cohort Study

    Vilhelm Sjögren, Bartosz Grzymala-Lubanski, Henrik Renlund, Peter J. Svensson & Anders Själander, 2017 nov 1, I: Clinical and Applied Thrombosis/Hemostasis. 23, 8, s. 961-966 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2016
  6. Intraoperative Hydroxyethyl Starch and its Effects on Different Fibrinogen Measurements.

    Dag Winstedt, Cristina Solomon, Andreas Hillarp, Tom Lundahl & Ulf Schött, 2016, I: Clinical and Applied Thrombosis/Hemostasis. 22, 7, s. 641-647

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2015
  8. Evaluation of Algorithms for the Treatment of Problem Bleeding Episodes in Patients With Hemophilia Having Inhibitors.

    Guy Young, Jerome Teitel, Roseline d'Oiron, Cindy Leissinger & Erik Berntorp, 2015, I: Clinical and Applied Thrombosis/Hemostasis. 21, 1, s. 10-18

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2011
  10. Controversies in Diagnosis of Pulmonary Embolism

    Paul D. Stein, H. Dirk Sostman, James E. Dalen, Dale L. Bailey, Marika Bajc, Samuel Z. Goldhaber, Lawrence R. Goodman, Alexander Gottschalk, Russell D. Hull, Fadi Matta, Massimo Pistolesi, Victor F. Tapson, John G. Weg, Philip S. Wells & Pamela K. Woodard, 2011, I: Clinical and Applied Thrombosis/Hemostasis. 17, 2, s. 140-149

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2010
  12. Pulmonary Embolism Associated With Protein C Deficiency and Abuse of Anabolic-androgen Steroids

    Alaa Alhadad, Stefan Acosta, Latif Sarabi & Tilo Kölbel, 2010, I: Clinical and Applied Thrombosis/Hemostasis. 16, 2, s. 228-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2006
  14. Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.

    Karin Strandberg, Stefan Lethagen, Kerstin Andersson, Margareta Carlson & Andreas Hillarp, 2006, I: Clinical and Applied Thrombosis/Hemostasis. 12, 1, s. 61-67

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 1997
  16. Activated protein C resistance: Clinical implications

    Bengt Zöller, Andreas Hillarp & Björn Dahlbäck, 1997 jan, I: Clinical and Applied Thrombosis/Hemostasis. 3, 1, s. 25-32 8 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. 1996
  18. Erythropoietin and desmopressin obviated transfusion in a thromboasthenic Jehovah's Witness undergoing scoliosis surgery

    Stefan Lethagen & Magnus K. Karlsson, 1996 jan 1, I: Clinical and Applied Thrombosis/Hemostasis. 2, 1, s. 11-13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Effect of low-molecular-weight heparin (Tinzaparin) and unfractionated heparin on platelet aggregation

    Hanne B. Ravn, Claus Bregengaard, Henrik Vissinger, Per Østergaard, Jan Holst, Hans K. Nielsen, Steen D. Kristensen & Steen E. Husted, 1996, I: Clinical and Applied Thrombosis/Hemostasis. 2, 3, s. 209-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift